Global Longlife Hospital re-appoints Manasvi Manu Thapar as Independent Director

2 min read     Updated on 26 Jun 2026, 04:57 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Global Longlife Hospital and Research Limited re-appointed Mr. Manasvi Manu Thapar as Independent Director for a second term of five years from September 10, 2026, to September 09, 2031, following shareholder approval at the AGM on June 25, 2026. All seven resolutions, including the re-appointment of Mr. Dhruv Jani as Managing Director and other key approvals, passed with 100% votes in favour.

powered bylight_fuzz_icon
43926047

*this image is generated using AI for illustrative purposes only.

Global Longlife Hospital and Research Limited re-appointed Mr. Manasvi Manu Thapar as Independent Director for a second term of five years, commencing from September 10, 2026, to September 09, 2031, following shareholder approval at its 15th Annual General Meeting (AGM) on June 25, 2026. The AGM, which commenced at 11:00 A.M. and concluded at 11:08 A.M., saw the re-appointment approved based on the Board of Directors' recommendation. Mr. Thapar is a legal professional with 10 years of experience and operates his own practice under the firm name Candour Legal.

Voting Results and Key Resolutions

Shareholders approved all seven resolutions through remote e-voting, with 36,88,990 votes cast in favour of every proposal, representing 100% of the total valid votes polled. The scrutinizer's report confirmed the requisite majority for all resolutions. No votes were cast during the physical AGM, as voting was conducted solely via remote e-voting from June 22, 2026, to June 24, 2026. The total number of shareholders on the record date of May 30, 2026, was 1158.

Sr. No Resolution Description Type Votes In Favour % of Votes
1 Adoption of Audited Financial Statements for FY26 Ordinary Resolution 36,88,990 100%
2 Re-appointment of Ms. Sucheta Jani (DIN: 06502321) Ordinary Resolution 36,88,990 100%
3 Appointment of Mr. Hiren Mandaliya (DIN: 11636452) as Independent Director Special Resolution 36,88,990 100%
4 Approval of Change in Name of the Company Special Resolution 36,88,990 100%
5 Alteration of Object clause of MOA Special Resolution 36,88,990 100%
6 Re-appointment of Mr. Dhruv Jani (DIN: 03154680) as Managing Director Special Resolution 36,88,990 100%
7 Re-appointment of Mr. Manasvi Manu Thapar (DIN: 07486932) as Independent Director Special Resolution 36,88,990 100%

Meeting and Compliance Details

The meeting was chaired by Mr. Dhruv Jani, Managing Director. Ms. Insiya Nalawala, Practicing Company Secretary, served as the scrutinizer for the e-voting process, with results witnessed by Mr. Mustansir Bhopali and Mr. Moiz Ezzi. Promoters and promoter groups held 24,01,990 shares, while public non-institutions held 80,98,010 shares. The statutory auditors, M/s. R.B. Gohil & Co., reported no qualifications on the financial transactions. The disclosure was made to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
+3.86%+15.56%-4.56%-49.39%-52.48%-91.66%

What strategic rationale drove the approval to change the company's name and alter its object clause?

How will the re-appointment of the Managing Director and new Independent Directors influence the company's long-term strategic direction?

What specific new business areas will the company pursue following the alteration of the Memorandum of Association's object clause?

Global Longlife Hospital & Research
View Company Insights
View All News
like16
dislike

Global Longlife Hospital seeks name change, MD re-appointment at AGM

2 min read     Updated on 02 Jun 2026, 05:06 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Global Longlife Hospital and Research Limited has announced its 15th Annual General Meeting for June 25, 2026, to be held via video conferencing. The primary agenda includes a proposal to change the company's name to Kanzi Enterprise Limited, Asahi Enterprise Limited, or Siddhaa Enterprise Limited and to alter the object clause to diversify into food, agriculture, and textile businesses. Additionally, the meeting seeks shareholder approval for the re-appointment of Dhruv Jani as Managing Director for a five-year term with a salary of up to ₹36 lakh per annum, along with the appointment of Independent Directors Hiren Mandaliya and Manasvi Thapar.

powered bylight_fuzz_icon
41683359

*this image is generated using AI for illustrative purposes only.

Global Longlife Hospital and Research Limited has scheduled its 15th Annual General Meeting (AGM) for June 25, 2026, through video conferencing, to seek shareholder approval for a significant change in corporate identity and leadership. The meeting will consider a special resolution to change the company's name to Kanzi Enterprise Limited, Asahi Enterprise Limited, or Siddhaa Enterprise Limited, subject to regulatory approvals. This proposed change aims to reflect the company's diversification and repositioning of business activities away from its current healthcare focus.

The Board of Directors, based on the recommendation of the nomination and remuneration committee, has approved the re-appointment of Mr. Dhruv Jani as Managing Director for a five-year term effective from September 10, 2026, to September 09, 2031. Mr. Jani, who serves as the Promoter and Managing Director, has held the position since September 10, 2021. His re-appointment is subject to shareholder approval and includes a remuneration package of up to ₹36,00,000 per annum. The meeting will also consider the re-appointment of Mr. Manasvi Manu Thapar as an Independent Director for a second term of five years and the appointment of Mr. Hiren Mandaliya as an Independent Director.

Business Diversification and Alteration of Objects

To align with its future growth plans, the company proposes to alter its object clause to include the manufacturing and trading of food products, spices, agricultural produce, and textiles. The new objectives encompass dealing in commodities such as edible oils, cotton, and garments, as well as trading in bullion and precious metals. This strategic shift requires shareholder approval via special resolution and subsequent amendments to the Memorandum of Association.

The Board believes the new name and diversified business activities will better represent the company's growth strategy. The change will not affect the rights or obligations of the shareholders or the company's constitution. The financial performance for the year ended March 31, 2026, showed a gross turnover of ₹0.52 lakh and a net loss of ₹171.95 lakh, with a net worth of ₹2374.93 lakh.

Key Meeting Details

Detail Information
Meeting Date Thursday, June 25, 2026
Time 11:00 A.M. IST
Mode Video Conferencing (VC) and Other Audio Visual Means (OAVM)
Remote E-voting Start Monday, June 22, 2026 at 09:00 A.M. IST
Remote E-voting End Wednesday, June 24, 2026 at 05:00 P.M. IST
Record Date Thursday, June 18, 2026

The regulatory filing was made to BSE Limited under Regulation 30 and 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ms. Sucheta Jani, a Non-Executive Director, is disclosed as the wife of Mr. Dhruv Jani. The notice is available on the company's website.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
+3.86%+15.56%-4.56%-49.39%-52.48%-91.66%

How will the company fund the capital-intensive shift into manufacturing and trading given the current net loss of ₹171.95 lakh?

What specific expertise does the current leadership possess to successfully pivot from healthcare to commodities and textiles?

How does the Board plan to mitigate the risks associated with entering highly competitive sectors like edible oils and bullion?

Global Longlife Hospital & Research
View Company Insights
View All News
like18
dislike

More News on Global Longlife Hospital & Research

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-52.48%